Sarepta Therapeutics (SRPT) Net Cash Flow Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 198.34% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 467.41% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14,223.53% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 453.08% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -125.22% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 53.46% |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn | 60.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 60.93% |
| Dec 31, 2025 | -79.21% |
| Sep 30, 2025 | 153.84% |
| Jun 30, 2025 | 717.69% |
| Mar 31, 2025 | -75,526.58% |
| Dec 31, 2024 | 873.16% |
| Sep 30, 2024 | 40.05% |
| Jun 30, 2024 | -121.23% |
| Mar 31, 2024 | 98.80% |
| Dec 31, 2023 | -62.95% |
| Sep 30, 2023 | -281.65% |
| Jun 30, 2023 | 94.46% |
| Mar 31, 2023 | 89.22% |
| Dec 31, 2022 | -113.89% |
| Sep 30, 2022 | 273.78% |
| Jun 30, 2022 | -265.46% |
| Mar 31, 2022 | -4,137.90% |
| Dec 31, 2021 | 1,714.55% |
| Sep 30, 2021 | 40.62% |
| Jun 30, 2021 | 273.39% |
| Mar 31, 2021 | -102.24% |
| Dec 31, 2020 | -74.14% |
| Sep 30, 2020 | -97.62% |
| Jun 30, 2020 | -255.98% |
| Mar 31, 2020 | 153.47% |
| Dec 31, 2019 | -31.58% |
| Sep 30, 2019 | 58.31% |
| Jun 30, 2019 | 154.19% |
| Mar 31, 2019 | 963.37% |
| Dec 31, 2018 | 998.14% |
| Sep 30, 2018 | -144.67% |
| Jun 30, 2018 | -38.19% |
| Mar 31, 2018 | -127.88% |
| Dec 31, 2017 | 93.42% |
| Sep 30, 2017 | 58.58% |
| Jun 30, 2017 | -244.10% |
| Mar 31, 2017 | 460.03% |
| Dec 31, 2016 | -1,213.82% |
| Sep 30, 2016 | 2,165.17% |
| Jun 30, 2016 | 1,607.10% |
| Mar 31, 2016 | -4,880.00% |
| Dec 31, 2015 | 15.21% |
| Sep 30, 2015 | 72.81% |
| Jun 30, 2015 | -109.13% |
| Mar 31, 2015 | 100.43% |
| Dec 31, 2014 | 227.42% |
| Sep 30, 2014 | -142.96% |
| Jun 30, 2014 | 557.24% |
| Mar 31, 2014 | -952.90% |
| Dec 31, 2013 | -111.14% |
| Sep 30, 2013 | 770.32% |
| Jun 30, 2013 | -92.93% |
| Mar 31, 2013 | -111.57% |
| Dec 31, 2012 | 2,419.81% |
| Sep 30, 2012 | 272.32% |
| Jun 30, 2012 | -119.68% |
| Mar 31, 2012 | 9.46% |
| Dec 31, 2011 | -171.32% |
| Sep 30, 2011 | -910.58% |